Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
DOUG Doug Elliman rises 374 percent as Q4 2025 revenue growth offsets steep earnings miss Norfolk Southern Corporation NSC Q1 2026 Earnings Dip on Temporary Winter Headwinds Merger Progress Signals LongTerm Bullish Upside Is Four FEDU stock trading above fair range 493 20260420 MarineMax HZO Q1 earnings fall short of estimates by 18 percent stock drops 184 percent today JANX Janux Therapeutics posts narrower Q4 2025 loss than estimates shares edge lower in todays trading ESH Acquisition ESHA reports first quarterly earnings since going public 028 EPS management outlines strategic roadmap American Express Company AXP Bullish Thesis Emerges Amid Mispricing Driven by ShortTerm Macro Concerns How SPX Technologies SPXC management quality drives results Falls 20260505 ProShares Ultra VIX ShortTerm Futures ETF UVXY Included in Broader 22ETF Forward and Reverse Split Announcement Effective November 20 2025 The GGRP Stock Today Drops 676 Key Support at 070 20260519 US Approves Apache Helicopter and M777 Howitzer Support Deals for India Team TISI Earnings Outlook Key Metrics for Q1 2026 Amplitech AMPGZ Q1 2026 Earnings Miss by Significant Key Takeaways Amicus Therapeutics FOLD Unchanged at 1449 RangeBound Trading 20260520 AZZ AZZ Q1 2026 Earnings Surge EPS 134 vs 123 Forecast Mazda Bets on Flagship CX5 SUV to Drive Growth Amid Rising Chinese Competition QLine Biotech IPO Day 1 Subscription Crosses 2x Mark as NIIs Lead Demand GMP Issue Details NCNO Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick INUV Q1 2026 Earnings EPS Surprises to the Upside with 17081 Beat Seagate Technology STX Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Demand OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech Ascentage Pharma AAPG Advances 22 as Biotech Sector Finds Footing BioVie Inc BIVI Declines 526 Testing Critical Support Near 137 Mesabi Trust MSB Declines Amid Broader Commodity Pressures Key Support Levels in Focus Solitario Resources XPL Slips 17 Tests Key Support Near 079